Somewhat confusing as to why we went into a trading halt. Was management expecting a re-rate of the SP? I'm glad they understand the science as it appears they misunderstood market sentiment at the moment. Biotech is still in an extreme bear market. Nothing seems to move the share price. Great buying opportunities in Biotech at the moment
Ann: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US, page-12
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.5¢ |
Change
0.001(1.06%) |
Mkt cap ! $26.10M | |||
| Open | High | Low | Value | Volume |
| 9.5¢ | 10.0¢ | 9.4¢ | $22.98K | 240.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 146804 | 9.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 52046 | 2 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| ATX (ASX) Chart |